Moriroku Company, Ltd.

4249.T
Specialty Chemicals
2026/08/06 Updated
Market Cap: $233.5M (¥36.8B)
Stock Price: $16.31 (¥2,573)
Exchange Rate: 1 USD = ¥157.73

Q1 2027 Fiscal Year Interim Earnings Materials

Discloses the highlights of the first quarter of the 2027 fiscal year. Consolidated net sales are 48.1 billion yen, operating income is 2.2 billion yen, and net income is about 1.6 billion yen. The contribution of the ReNova business and segment details are shown, with many unclear points such as revisions to forecasts; overall suggests growth potential.

Importance:
Page Updated: August 6, 2026
IR Disclosure Date: August 6, 2026

Key Figures

  • Net sales: 481億円
  • Operating income: 22億円
  • Net income: 16億円

AI要約

Overview of performance

Consolidated net sales for the first quarter of this period are 48.1 billion yen, operating income is 2.2 billion yen, and the breakdown of ordinary income and net income is provided by segment. The breakdown by business segment including the ReNova business is laid out in the materials, with accompanying charts illustrating trends in selling, general and administrative expenses and cost structure. Overall, attention is on the contribution of specific segments, with this material structure aimed at evaluating the effects of restructuring and integration.

Outlook and notes

The breakdown of segment sales and profits in the supplementary materials could directly influence future earnings forecast revisions and policy decisions. Going forward, progress reports in subsequent quarters and ongoing assessment of the ReNova business contribution will be important.

Revenue Trend

Operating Income Trend

Segment Revenue

Margin Analysis

This page uses AI to summarize IR materials from TDnet. Please refer to the original document for investment decisions.

Mori6 Holdings Co., Ltd.

Company overview · Stock price · Financial data · All IR

View company page →